Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 397

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 397
---
 our IPO if we extend the period of time to consummate a business combination) (the “Combination Period”),
or (B) with respect to any other provision relating to stockholders’ rights or pre-Business Combination activity, and (iii) the
redemption of all of the Company’s public shares if the Company is unable to complete the Business Combination within the Combination
Period, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s
creditors, if any, which could have priority over the claims of the Company’s public stockholders.

The Company provided its public
stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination
in connection with a stockholder meeting called to approve the initial Business Combination. The decision as to whether the Company will
seek stockholder approval of a proposed initial Business Combination or conduct a tender offer was made by the Company, solely in its
discretion. The stockholders were entitled to redeem all or a portion of their public shares upon the completion of the initial Business
Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business
days prior to the consummation of the initial Business Combination, including interest (which interest shall be net of taxes payable)
divided by the number of then outstanding public shares, subject to the limitations described herein. The per share amount the Company
distributed to investors who properly redeemed their shares was not reduced by the fee payable to I-Bankers and Dawson James
pursuant to the Business Combination Marketing Agreement (see Note 6).

On March 10, 2023, the
Company held a vote to amend its amended and restated certificate of incorporation to extend the date by which the Company must consummate
a Business Combination from March 22, 2023 to December 22, 2023 (the “First Extension Meeting”).

On December 21, 2023,
the Company held a special meeting of stockholders to vote on extending the Combination Period. As a result, the Company extended the
Combination Period from December 22, 2023 to March 22, 2024. In connection with the extension, 140,663 shares of the Company’s
common stock were redeemed, with 6,027,219 shares of Common Stock remaining outstanding after the Redemption; 833,469 shares of Common
Stock